Anna Dunalska

Dr. Anna Dunalska

Medical University of Warsaw
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
ADAnna Dunalska
Anna Dunalska
KSKamila Saramak
Kamila Saramak
Natalia SzejkoNatalia Szejko
Natalia Szejko
Multiple sclerosis (MS) is a chronic, progressive neuroinflammatory disease with a complex pathophysiological background. A variety of diverse factors have been attributed to the propagation of inflammation and neurodegeneration in MS, mainly genetic, immunological, and environmental factors such as vitamin D deficiency, infections, or hormonal disbalance. Recently, the importance of the gut-brain axis for the development of many neurological conditions, including stroke, movement disorders, and neuroinflammatory disorders, has been postulated. The purpose of our paper was to summarize current evidence confirming the role of the gut microbiome in the pathophysiology of MS and related disorders, such as neuromyelitis optica spectrum disorder (NMO-SD). For this aim, we conducted a systematic review of the literature listed in the following databases: Medline, Pubmed, and Scopus, and were able to identify several studies demonstrating the involvement of the gut microbiome in the pathophysiology of MS and NMO-SD. It seems that the most relevant bacteria for the pathophysiology of MS are those belonging to Pseudomonas, Mycoplasma, Haemophilus, Blautia, Dorea, Faecalibacterium, Methanobrevibacter, Akkermansia, and Desulfovibrionaceae genera, while Clostridium perfringens and Streptoccocus have been demonstrated to play a role in the pathophysiology of NMO-SD. Following this line of evidence, there is also some preliminary data supporting the use of probiotics or other agents affecting the microbiome that could potentially have a beneficial effect on MS/NMO-SD symptoms and prognosis. The topic of the gut microbiome in the pathophysiology of MS is therefore relevant since it could be used as a biomarker of disease development and progression as well as a potential disease-modifying therapy.

31 December 2021 in Psychiatria Polska
Verified
Journal Article
Open access
ADAnna Dunalska
Anna Dunalska
MRMarcin Rzeszutek
Marcin Rzeszutek
ZDZuzanna Dębowska
Zuzanna Dębowska
ABAnita Bryńska
Anita Bryńska
Zaburzenia ze spektrum autyzmu (Autism Spectrum Disorders; ASD) to heterogenna grupa zaburzeń neurorozwojowych, która może dotyczyć nawet 2,6% populacji. U większości z tych osób w ciągu życia pojawi się przynajmniej jedno inne zaburzenie psychiczne, często rozpoznane z opóźnieniem lub nie rozpoznane wcale. W tej pracy opisano epidemiologię, trudności diagnostyczne oraz potencjalne leczenie pacjentów z ASD i współwystępującą chorobą afektywną dwubiegunową (CHAD). Wskaźniki rozpowszechnienia CHAD w ASD wahają się od 0% do 31%. Badanie na najliczniejszej grupie dotyczyło 700 000 dzieci i wykazano w nim, że 21% pacjentów z ASD spełniało kiedykolwiek kryteria manii. Na trudności w rozpoznawaniu współwystępowania obu zaburzeń ma wpływ wiele czynników. Ze względu na specyfikę schorzenia pacjenci z ASD mają często ograniczony wgląd w rozumienie złożonych stanów emocjonalnych oraz trudno je komunikują. Co więcej, objawy CHAD są w przypadku tej grupy niespecyficzne i różnią się od tych występujących w populacji ogólnej, co utrudnia postawienie rozpoznania nawet doświadczonym lekarzom. Mimo braku badań dotyczących ich trafności w grupie pacjentów z ASD do stawiania diagnoz stosowane są narzędzia psychometryczne stworzone do ewaluacji populacji ogólnej. Farmakoterapia przy współwystępującymi CHAD i zaburzeniach ze spektrum autyzmu jest niewystarczająco zbadana i opiera się głównie na seriach przypadków. Ta praca ma na celu pokazanie stanu obecnej wiedzy oraz obszarów, które wymagają dalszego dokładnego zbadania.

4 May 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
ADAnna Dunalska
Anna Dunalska
JPJulia Pikul
Julia Pikul
KSKatarzyna Schok
Katarzyna Schok
KWKatarzyna Anna Wiejak
Katarzyna Anna Wiejak
PAPiotr Alster
Piotr Alster
Corticobasal syndrome (CBS) is a clinical entity, classified as an atypical Parkinsonism, characterized by both motor and higher cortical dysfunctions. The clinical manifestation of CBS is associated with several pathologies, among which corticobasal degeneration (CBD) is the most common. The aim of our study was to elaborate on the possible vascular pathogenesis of CBS and consider types of vascular lesions in these cases. Several cases of vascular CBS are described in the literature. The majority of presented patients were affected by internal carotid artery (ICA) stenosis and ischemic strokes; few cases were associated with vascular malformations or autoimmune diseases. Vascular CBS is preceded by an abrupt onset. The clinical manifestation does not significantly differ with non-vascular CBS. Patients with vascular CBS are usually elderly; often with coexistent hypertension, dyslipidemia and diabetes mellitus. Inferring from our observations, cerebral hypoperfusion can play a significant role in neuropathological changes in neurodegenerative diseases. To the best of our knowledge paper is the first comprehensive review of vascular CBS and we are positive that our observations show that further research concerning the vascular pathogenesis of tauopathy atypical Parkinsonism is required.

11 December 2018 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Open access
PDF file
NSNatalia Szejko
Natalia Szejko
AJAndrzej Jakubczyk
Andrzej Jakubczyk
ADAnna Dunalska
Anna Dunalska
Piotr JanikPiotr Janik
Piotr Janik
Clinical rationale for the study. Gilles de la Tourette syndrome (GTS) is a childhood onset disorder characterised by motor and vocal tics. Different types of motor tics may occur in GTS, including dystonic tics (DTs). Although DTs have been recognised as part of GTS symptomatology, little is known about their risk factors or about how often and at what age they appear in affected individuals. Aim of the study. The aim of our study was to investigate lifetime prevalence and clinical correlations of DTs in a Polish cohort of GTS patients. Material and methods. We performed a prospective, one-registration study in a cohort of 207 consecutive ambulatory patients (mean age: 16.5 ± 9.4 years, 131 children, 162 males) with GTS. Duration of GTS was 9.0 ± 8.0 years (range: 1–39 years). DTs were diagnosed during the interview. DTs were defined as slower and lasting longer than typical clonic tics, abnormal dystonia-like movements that led to a sustained, but not fixed, posture. Results. DTs occurred at some point in the lifetime of 73.9% (n = 153) of patients. The prevalence of DTs in adults and children was almost the same (p = 0.963). Age at onset of DTs was 9.9 ± 5.2 years with the most frequent onset in children (7–11 years, 74.4%, n = 64), followed by adolescence (12–18 years; 17.4%, n = 15) and adulthood (≥ 18 years, 8.1%, n = 7). DTs occurred 3.7 ± 4.2 years after tic onset. On average, patients suffered from 1.8 ± 1.7 types of DTs. The most frequent manifestations of DTs were: eyes (tightening resembling blepharospasm 84.3%, n = 129 and oculogyric crisis 45.8%, n = 70), trunk (dystonic postures 59.5%, n = 91), jaw (bruxism 34.6%, n = 53), neck (30.7%, n = 47), upper limb (26.1%, n = 40), and foot (20.9%, n = 32). Multivariate logistic regression analysis showed significant associations of DTs with the total number of simple, and the total number of complex, tics. Conclusions and clinical implications. DTs are early and frequent symptoms of GTS. They tend to localise in the facial area. DTs occur more frequently in individuals with a higher number of tics and probably add to the global impairment caused by tics. Clinical rationale for the study. Gilles de la Tourette syndrome (GTS) is a childhood onset disorder characterised by motor and vocal tics. Different types of motor tics may occur in GTS, including dystonic tics (DTs). Although DTs have been recognised as part of GTS symptomatology, little is known about their risk factors or about how often and at what age they appear in affected individuals. Aim of the study. The aim of our study was to investigate lifetime prevalence and clinical correlations of DTs in a Polish cohort of GTS patients. Material and methods. We performed a prospective, one-registration study in a cohort of 207 consecutive ambulatory patients (mean age: 16.5 ± 9.4 years, 131 children, 162 males) with GTS. Duration of GTS was 9.0 ± 8.0 years (range: 1–39 years). DTs were diagnosed during the interview. DTs were defined as slower and lasting longer than typical clonic tics, abnormal dystonia-like movements that led to a sustained, but not fixed, posture. Results. DTs occurred at some point in the lifetime of 73.9% (n = 153) of patients. The prevalence of DTs in adults and children was almost the same (p = 0.963). Age at onset of DTs was 9.9 ± 5.2 years with the most frequent onset in children (7–11 years, 74.4%, n = 64), followed by adolescence (12–18 years; 17.4%, n = 15) and adulthood (≥ 18 years, 8.1%, n = 7). DTs occurred 3.7 ± 4.2 years after tic onset. On average, patients suffered from 1.8 ± 1.7 types of DTs. The most frequent manifestations of DTs were: eyes (tightening resembling blepharospasm 84.3%, n = 129 and oculogyric crisis 45.8%, n = 70), trunk (dystonic postures 59.5%, n = 91), jaw (bruxism 34.6%, n = 53), neck (30.7%, n = 47), upper limb (26.1%, n = 40), and foot (20.9%, n = 32). Multivariate logistic regression analysis showed significant associations of DTs with the total number of simple, and the total number of complex, tics. Conclusions and clinical implications. DTs are early and frequent symptoms of GTS. They tend to localise in the facial area. DTs occur more frequently in individuals with a higher number of tics and probably add to the global impairment caused by tics.

Verified
Journal Article
Open access
PDF file
Piotr JanikPiotr Janik
Piotr Janik
ADAnna Dunalska
Anna Dunalska
Natalia SzejkoNatalia Szejko
Natalia Szejko
AJAndrzej Jakubczyk
Andrzej Jakubczyk
Coprolalia and echophenomena repeated in the patients’ mind (CTPh—cognitive tic-like phenomena) have been rarely recognized as part of Gilles de la Tourette syndrome (GTS) symptomatology and their assignment to tics, OCD or other psychopathologies has not been settled. The aim of the paper was to assess the incidence and clinical associations of CTPh in GTS, and to establish if CTPh belong to the tic spectrum. We performed a prospective, one-registration study on a cohort of 227 consecutive patients with GTS. CTPh were diagnosed during the interview and defined as brief, sudden, involuntary thoughts that had corresponding complex vocal tics. CTPh occurred at some point in the lives of 34 (15.0%) patients. The median age at onset of CTPh was 14.5 years (IQR: 10.5–17.5). CTPh were found more frequently in adults, with the most frequent onset in adolescence (44.1%). Four mental phenomena resembling tics were recognized: echolalia (n = 17), coprolalia (n = 16), palilalia (n = 13) and repeating of words in the mind (n = 7). The older the age of patients, the more severe tics, and anxiety disorder significantly correlated with CTPh. CTPh may be considered as a part of tic spectrum with a substantial impact of anxiety disorder. CTPh are a late and age-related symptom of GTS.

27 January 2026 in Journal of Psychiatric Research
Verified
Journal Article
Open access
ADAnna Dunalska
Anna Dunalska
AJAndrzej Jakubczyk
Andrzej Jakubczyk
ASAgata Szulc
Agata Szulc
Natalia SzejkoNatalia Szejko
Natalia Szejko
Dissociative symptoms are increasingly recognized beyond trauma-related and dissociative disorders, yet their role in depressive and anxiety disorders remains understudied, particularly in routine clinical settings. This cross-sectional study examined the prevalence and clinical correlates of dissociative symptoms in 133 adult outpatients with depressive and/or anxiety disorders prior to pharmacological treatment. Dissociation was assessed using the Dissociative Experiences Scale-Revised (DES-R) and the Somatoform Dissociation Questionnaire-20 (SDQ-20), distinguishing between psychoform and somatoform dissociation subtypes. Clinically significant dissociation was observed in 12 % of participants (DES-R) and 18.8 % (SDQ-20). Preoccupation and imaginal involvement were the most common psychoform symptoms, whereas somatoform symptoms were widespread, with no significant difference between the positive and negative subtypes. Somatoform dissociation showed a moderate correlation with anxiety, especially somatic anxiety, whereas psychoform dissociation was only weakly associated with anxiety severity. Interaction and mediation analyses revealed distinct pathways: psychoform dissociation was independently associated with both depression and anxiety, and the nonlinear interaction suggested a saturation effect at high levels of depression. In contrast, somatoform dissociation was indirectly associated with depression via anxiety, suggesting a mediating role. These findings support the disconnection and compartmentalization theory and indicate that dissociative symptoms, even in the absence of trauma, can complicate the clinical presentation of depressive and anxiety disorders. Given that more than 10 % of participants met criteria for both severe depressive and anxiety symptoms and pathological dissociation, routine screening for dissociation seems warranted in psychiatric assessment and treatment planning.